Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 112, Issue 3, 690-698, August 1, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Up-regulation of c-FLIPshort by NFAT contributes to apoptosis resistance of short-term activated T cells
Blood Ueffing et al. 112: 690

Supplemental materials for: Ueffing et al

Files in this Data Supplement:

  • Document 1. Supplemental materials and methods (PDF, 832 KB)

  • Figure S1. Effect of different signaling pathway inhibitors on c-FLIP expression (JPG, 52.8 KB) -
    (A) Human peripheral T cells were treated for 16 h with 5 µg/ml PHA-L in the presence or absence of 20 µM PD098059 (MEK1 inhibitor), 1 µM SB 203580 (p38 inhibitor), or 1 µM cyclosporine A (CsA) (d1 T cells). Subsequently, cells were analyzed by Western blotting. Freshly prepared T cells (d0 cells) served as a control. (B) Inhibition of mitogen-activated protein kinases (MAPK), phosphatidylinositol 3-kinase (PI3K), mammalian target of rapamycin (mTOR) or glycogen synthase kinase 3 beta (GSK3β) does not interfere with induction of c-FLIPshort in primary T cells. Human peripheral T cells were immediately lysed (d0) after isolation or stimulated for 16 h (d1) with either 5 µg/ml PHA-L or PHA-L plus 1 µM cyclosporine A (CsA), 25 µM roscovitine (Ros, Cdk2 inhibitor), 1 or 100 nM rapamycin (mTOR inhibitor), 3 µM SB415286 (GSK3β inhibitor), 50 nM PD098059 (MEK1 inhibitor), 50 nM SB203580 (p38 inhibitor), 1 µM JNK-II, or 10 nM wortmannin (WM, PI3K inhibitor). c-FLIP expression was analyzed by Western blotting. Tubulin or β¬actin served as a loading control. Note that roscovitine inhibited not only c-FLIPshort expression but also T cell activation, as revealed by a strong downregulation of the activation markers CD25 and CD69 (data not shown).





  • Figure S2 (JPG, 50.7 KB) -
    (A) Regulation of c-FLIP expression in CEM cells. Cells were stimulated for the indicated time with 20 ng/ml PMA and 1 µM ionomycin in the absence or presence of 1 µM CsA or 10 µg/ml cycloheximide (CHX) and c-FLIP expression was analyzed by Western blot. Tubulin served as a loading control. (B) Controls for the ChIP experiments in CEM cells. The panel shows a ChIP with rabbit control IgG and anti-acetylated histone-3 (Ac-H3) that served as negative and positive control for the ChIP procedure shown in Figure 5C. Here, the GAPDH promoter was analyzed as a constitutively transcribed gene. Genomic DNA (input) and water were used as positive and negative controls for PCR analysis.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020